Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 134 of 144 pages ‹ First < 132 133 134 135 136 > Last ›
HSL1736
Freudenheim M.
Drug Spending Rises Sharply At Pharmacies and by Mail
The New York Times 2002 Mar 29
http://select.nytimes.com/gst/abstract.html?res=F30B13FC345F0C7A8EDDAA0894DA404482
HSL1737
Connolly C.
Medication Spending Continues Steady Rise
Washington Post 2002 Mar 29
HSL1738
Carroll J.
Rise in Prescription-Drug Spending May Mean Steeper Premiums Ahead
The Wall Street Journal 2002, Mar 29
http://online.wsj.com/article/SB1017351626393985960.html?mod=googlewsj
HSL1734
O'Connell V.
Drug Marketers' Ads Penetrate Text of Online Medical Studies
Wall Street Journal 2002 Mar 28
http://online.wsj.com/article/SB1017264444467884800.html?mod=googlewsj
HSL1733
Arno P.
Paying Twice for the Same Drugs
Washington Post 2002 Mar 27
http://www.washingtonpost.com/ac2/wp-dyn/A22829-2002Mar26?language=printer
HSL1732
Walsh M.
When a Buyer for Hospitals Has a Stake in Drugs It Buys
New York Times 2002 Mar 26
http://www.nytimes.com/2002/03/26/business/when-a-buyer-for-hospitals-has-a-stake-in-drugs-it-buys.html?pagewanted=1
HSL1731
Zuckerman D.
Is Drug Safety Being Enron'd?
redflagsweekly 2002 Mar 25
HSL28
Lenzer J.
Alteplase for stroke: money and optimistic claims buttress the “brain attack“ campaign.
BMJ 2002 Mar 23; 324:723-726
http://bmj.bmjjournals.com/cgi/content/full/324/7339/723
HSL1730
McGregor .
Ban on drug ads to stay: McLellan
The Ottawa Citizen 2002 Mar 23
HSL1974
Orellana C.
German doctors' links with drug firm investigated.
Lancet 2002 Mar 23; 359:(9311):1039
http://linkinghub.elsevier.com/retrieve/pii/S0140673602081126
HSL1729
The menace of fake drugs in Nigeria
2002 Mar 22
HSL1728
McNeil D.
New List of Safe AIDS Drugs, Despite Industry Lobby
New York Times 2002 Mar 21
http://www.nytimes.com/2002/03/21/world/new-list-of-safe-aids-drugs-despite-industry-lobby.html?pagewanted=1
HSL20239
Winkens R, Dinant G-J
Rational, cost effective use of investigations in clinical practice
BMJ 2002 Mar 20; 324:
HSL1727
Health-literate patients-an asset to society
European Federation of Pharmaceutical Industries and Associations 2002 Mar 19
HSL1725
Pallarito K.
Lawmakers pass resolution to press US Congress on lower drug prices
Reuters Health 2002 Mar 15
HSL1726
Fuhrmans V.
European Drug Makers May Utilize More Aggressive Marketing Tactics
The Wall Street Journal 2002 Mar 15
http://online.wsj.com/article/SB1016129314345304480.html?mod=googlewsj
HSL7764
Young D.
FTC-Lilly settlement sheds light on e-mail privacy with patients.
Am J Health Syst Pharm 2002 Mar 15; 59:(6):509
http://www.ajhp.org/
HSL7983
Williams C.
Aspirin Can't Cure Bayer's Aches
Los Angeles Times 2002 Mar 15C4
http://pqasb.pqarchiver.com/latimes/access/110557388.html?dids=110557388:110557388&FMT=ABS&FMTS=ABS:FT&type=current&date=Mar+15%2C+2002&author=CAROL+J.+WILLIAMS&pub=Los+Angeles+Times&edition=&startpage=C.4&desc=Aspirin+Can%27t+Cure+Bayer%27s+Aches
HSL1722
Adams C.
FDA Is Inundated Trying To Assess Drug Ad Pitches
The Wall Street Journal 2002 Mar 14
http://online.wsj.com/article/SB1016053991820089240.html?mod=googlewsj
HSL1723
Hensley S.
More Than Ads, Drug Makers Rely on Sales Representatives
The Wall Street Journal 2002 Mar 14
HSL1724
Petersen M.
Whistle-Blower Says Marketers Broke the Rules to Push a Drug
New York Times 2002 Mar 14
http://www.nytimes.com/2002/03/14/business/whistle-blower-says-marketers-broke-the-rules-to-push-a-drug.html?pagewanted=all
HSL1717
Gardiner H.
Drug Makers Offer Consumers Coupons for Free Prescriptions
The Wall Street Journal 2002 Mar 13
http://online.wsj.com/article/0,,SB1015968588107926720.djm,00.html
HSL1718
Burton T.
Backlash Rises Against Flashy Ads For Prescription Pharmaceuticals
The Wall Street Journal 2002 Mar 13
http://online.wsj.com/article/SB1015968026351450840.html?mod=googlewsj
HSL1719
O'Connell V.
Ad Agencies Begin to Participate In Development of New Drugs
The Wall Street Journal 2002 Mar 13
HSL1721
German Public Prosecutor investigates doctors who have received gifts from GSK
Trouw newspaper 2002 Mar 13
HSL1715
Cleaver H.
Bribery of German Docs by Drug Companies
2002 Mar 11
http://story.news.yahoo.com/news?tmpl=story&cid=594&u=/nm/20020311/hl_nm/germany_docs_1
HSL1712
Metherell M.
Patients face drug rations
Sydney Morning Herald 2002 Mar 9
HSL1714
Craig T
Community Leaders Decry Lobby Firm's Fax
Baltimore Sun 2002 Mar 9
http://www.commondreams.org/headlines02/0309-04.htm
HSL16131
Eysenbach G, Köhler C.
How do consumers search for and appraise health information on the world wide web? Qualitative study using focus groups, usability tests, and in-depth interviews.
BMJ. 2002 Mar 9; 324:(7337):573-7
http://www.bmj.com/cgi/content/full/324/7337/573?view=long&pmid=11884321
HSL1710
Moynihan R.
ACA urges cut to $4bn drug bill
Australian Financial Review 2002 Mar 8
HSL1711
Petersen M
TV Ads Spur a Rise in Prescription Drug Sales
New York Times 2002 Mar 8
http://www.nytimes.com/2002/03/08/business/08PRES.html
HSL1709
Italy suspends sales of sibutramine over adverse events
Reuters Health 2002 Mar 7
HSL1708
Avantago introduces mobile application built specifically for pharmaceutical sales
HAYWARD 2002 Mar 4
HSL17915
Avantgo Introduces Mobile Application Built Specifically For Pharmaceutical Sales
AvantGo, Inc 2002 Mar 4
HSL1713
Ottawa must protect public from drug ads
The Toronto Star 2002 Mar 3
HSL1707
Treating depression
2002 Mar 1
HSL2485
Castaigne A.
[Role of drugs in therapeutic strategies].
Rev Prat. 2002 March 1; 52:(5):491-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11949500
HSL7808
Young D.
Drug industry sues states over prescription programs for low-income residents.
Am J Health Syst Pharm 2002 Mar 1; 59:(5):408
http://www.ajhp.org/cgi/pmidlookup?view=reprint&pmid=11887405
HSL1716
How does pharmaceutical marketing influence doctors' prescribing behaviour?
2002 Mar
HSL1720
Jung P.
No Free Lunch
Health Affairs 2002 Mar
http://content.healthaffairs.org/cgi/content/full/21/2/226
HSL1741
McKinnell H.
Towards a sustainable solution - funding innovative medicines
Pharmapolicy News 2002 Mar
HSL1933
Spilker B.
The benefits and risks of a pack of M&Ms: A pharmaceutical spokesman answers his industry's critics
Health Affairs 2002 3-4; 21:(2):243-244
http://content.healthaffairs.org/cgi/reprint/21/2/243?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Spilker+B&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
HSL1965
Rao SK.
Pharmaceutical marketing in a new age, Effective campaigns still need to focus on what customers want.
Mark Health Serv 2002 Spring; 22:(1):6-12
HSL2077
Hall KH.
Reviewing intuitive decision-making and uncertainty: the implications for medical education.
Med Educ 2002 Mar; 36:(3):216-24
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1365-2923.2002.01140.x
HSL2247
Kunst H, Khan KS.
Quality of web-based medical information on stable COPD: comparison of non-commercial and commercial websites.
Health Info Libr J 2002 Mar; 19:(1):42-8
http://www.blackwell-synergy.com/doi/abs/10.1046/j.0265-6647.2001.00363.x
HSL2472
D'Mello B.
Transnational pharmaceutical corporations and neo-liberal business ethics in India.
J Bus Ethics 2002 Mar; 36:(1-2):165-85
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12625343
HSL2474
Davidoff F.
Between the lines: Navigating the uncharted territory of industry-sponsored research: A former medical journal editor describes how and why staff changed their policy on disclosing conflicts of interest.
Health Affairs 2002 Mar-Apr; 21:(2):235-242
http://www.medscape.com/viewarticle/429526
HSL2480
Cocconi G.
Independent clinical trials: a commentary.
Tumori 2002 Mar-Apr; 88:(2):85-8
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12088263
HSL2489
Brody H.
A matter of influence: Changing times call for changing policies on the prescence of drug company reps in residency programs
Health Affairs (Millwood). 2002 Mar-Apr; 21:(2):232-234
http://www.healthaffairs.org/freecontent/s28.htm
HSL6986
de Laat E, Windmeijer F, Douven R
How does pharmaceutical marketing influence doctors' prescribing behaviour?
2002 Mar
http://www.cpb.nl/nl/news/2002_11.html
HSL7759
Newton GD, Benninghoff AJ, Pray WS, Popovich NG.
New OTC drugs and devices 2001: a selective review.
J Am Pharm Assoc (Wash) 2002 Mar-Apr; 42:(2):267-77
HSL17917
Background on the Prescription Drug User Fee Act
Patient and Consumer Coalition 2002 Mar
HSL1682
Timmerman L.
Prescription plan becomes a racial issue
Seattle Times business reporter 2002 Feb 27
http://community.seattletimes.nwsource.com/archive/?date=20020227&slug=drughearing270
HSL1683
Johnson E.
Direct-to-consumer advertising
2002 Feb 27
HSL1684
Excepts from advertisements for mobile sales information systems from AvantGo
2002 Feb 27
HSL1681
FDA hits Elan, Pharmacia and Roche on ad practices
FDA news Daily Bulletin 2002 Feb 26
HSL1680
Pallarito K.
Vermont bill would impose fees on drug detailers
Reuters Health 2002 Feb 25
HSL1679
Ross B, Scott DW.
Do Drug Company Perks Influence Doctors? How Pharmaceutical Companies Use Enticement to ‘Educate’ Physicians
ABC News USA 2002 Feb 21
http://abcnews.go.com/Primetime/story?id=132141&page=1
HSL5592
Shann F.
Research in developing countries.
N Engl J Med 2002 Feb 21; 346:(8):627-8
HSL1839
Glazer JL.
Pharmaceutical representatives and resident physicians.
JAMA 2002 Feb 20; 287:(7):844
http://jama.ama-assn.org/cgi/content/full/287/7/844
HSL1936
Shuchman M.
The Olivieri dispute: no end in sight?
CMAJ 2002 Feb 19; 166:(4):487
http://www.cmaj.ca/cgi/content/full/166/4/487, http://www.cmaj.ca/cgi/reprint/166/4/487.pdf
HSL2465
Gibson E, Baylis F, Lewis S.
Dances with the pharmaceutical industry.
CMAJ 2002 Feb 19; 166:(4):448-50
http://www.cmaj.ca/cgi/pmidlookup?view=long&pmid=11873922
HSL2679
Questions of interest
Canadian Medical Association Journal 2002 Feb 19; 166:(4):413
HSL17980
Naylor CD
Early Toronto experience with new standards for industry-sponsored clinical research: a progress report
CMAJ 2002 Feb 19; 166:(4):453
http://www.ecmaj.com/cgi/content/full/166/4/453
HSL1257
Wolfe SM.
Direct-to-consumer advertising--education or emotion promotion?
N Engl J Med 2002 Feb 14; 346:(7):524-6
http://content.nejm.org/cgi/content/extract/346/7/524
HSL1676
Drug companies are increasingly targeting patients
Associated Press 2002 Feb 14
HSL1678
Connolly C.
Drug Marketers Focus on Doctors: Consumer Ads Up -- but Still Secondary
Washington Post 2002 Feb 14
www.washingtonpost.com/wp-dyn/articles/A7256-2002Feb13.html
HSL2455
Holmer AF.
Direct-to-consumer advertising--strengthening our health care system.
N Engl J Med 2002 Feb 14; 346:(7):526-8
http://content.nejm.org/cgi/content/extract/346/7/526
HSL2471
Drazen JM.
The consumer and the learned intermediary in health care.
N Engl J Med 2002 Feb 14; 346:(7):523-4
http://content.nejm.org/cgi/content/full/346/7/523
HSL17981
Lee TH, Brennan TA.
Direct-to-consumer marketing of high-technology screening tests.
N Engl J Med 2002 Feb 14; 346:(7):529-31
http://content.nejm.org/cgi/content/extract/346/7/529
HSL1675
Heinzl J.
Drug makers said to skirt Canadian restrictions on ads
Globe and Mail 2002 Feb 12
HSL1677
Neurontin (GABAPENTIN)--The Illegal Corporate Creation of a Blockbuster Drug
Public Citizen 2002 Feb 12
https://www.worstpills.org/login.cfm?redirected=1&page=/member/newsletter.cfm&qString=n_id%3D62
HSL1674
Spencer C.
Everyone gets to know about prescriptions -- except the patient
The Ottawa Citizen 2002 Feb 11
HSL1673
HAI DTCA statement
2002 Feb 10
http://www.haiweb.org/campaign/DTCA/index.html
HSL19524
Katz D
Bioethics on NBC's ER: The Agony and the Ecstasy of Free Lunch
Bioethics.net 2002 Feb 10;
http://bioethics.net/articles.php?viewCat=7&articleId=163
HSL1671
Boseley S.
Scandal of scientists who take money for papers ghostwritten by drug companies: Doctors named as authors may not have seen raw data
The Guardian 2002 Feb 7
HSL1672
Boseley. S
'It said the drug was the best thing since sliced bread. I don't think it is'.
The Guardian. 2002 Feb 7
http://www.guardian.co.uk/uk/2002/feb/07/research.health
HSL1670
Stolberg S.
Study Says Clinical Guides Often Hide Ties of Doctors
New York Times 2002 Feb 6
http://www.nytimes.com/2002/02/06/health/06DRUG.html?pagewanted=1
HSL1669
Direct-to-Consumer Advertising of Pharmaceuticals
2002 Feb 5
HSL2249
Komesaroff PA, Kerridge IH.
Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry
Med J Aust 2002 Feb 4; 176:(3):118-21
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11936308
HSL16526
Bamforth I
Knock: a study in medical cynicism
Medical Humanities 2002 Feb 4; 28:(1):14
http://mh.bmj.com/cgi/content/full/28/1/14
HSL1667
Mansfield P, Evans A.
Costs are important but it's medicines that save lives
Australian Financial Review 2002 Feb 2
HSL1668
Picard A.
Patients requesting advertised drugs
GLOBE AND MAIL 2002 Feb 2
HSL7762
Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, Evans RG, Pan R, Marion SA.
Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey.
BMJ 2002 Feb 2; 324:(7332):278-9
http://www.bmj.com/cgi/content/full/324/7332/278
HSL20088
Brook S
Bones of contention
The Weekend Australia 2002 Feb 224
HSL1665
Jack I.
Majority wants drug ads legalized, poll shows
Financial Post: Canada 2002 Feb 1
HSL1666
68% of Canadians Support Direct to Consumer Advertising for Prescription Medications
Ipsos-Reid 2002 Feb 1
http://www.ipsos-reid.com/media/dsp_displaypr_cdn.cfm?id_to_view=1417
HSL3690
Mintzes B, Barer ML, Kazanjian A, Bassett K, Evans RG, Morgan S.
An assessment of the health system impact of direct-to-consumer advertising of prescription medicines (DTCA). Volume I: Executive Summary.
: Centre for Health Services and Policy Research. Date uncertain 2002 Feb 01
http://www.chspr.ubc.ca/hpru/pdf/dtca-v1-execsum.pdf
HSL5289
Barclay S, Todd C, Finlay I, Grande G, Wyatt P.
Not another questionnaire! Maximizing the response rate, predicting non-response and assessing non-response bias in postal questionnaire studies of GPs.
Fam Pract 2002 Feb 01; 19:(1):105-11
http://fampra.oxfordjournals.org/cgi/content/full/19/1/105
HSL1664
RiviÈre P.
Drug deals in Europe
Le Monde diplomatique 2002 Feb
http://MondeDiplo.com/2002/02/05drugs
HSL1685
Sandvik H.
Norwegian GPs Protest Withdrawal of Cheap Antihypertensives
Wonca News 2002 Feb
http://www.globalfamilydoctor.com/publications/woncaNews
HSL1931
Studin I.
Reframing the pharmaceutical manufacturer/health plan relationship in managed care.
Manag Care 2002 Feb; 11:(2):46,
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11904913http://
HSL2150
Mintzes , B. et al.
An assessment of the health system impacts of direct- to-consumer advertising of prescription medicines (DTCA)
Vancouver: Centre for Health Services and Policy research, The University of British Columbia 2002 Feb
http://www.chspr.ubc.ca/hpru/pdf/dtca-v1-execsum.pdf
HSL2461
Haugh R, Thrall TH, Scalise D.
Prescription for concern.
Hosp Health Netw 2002 Feb; 76:(2):44-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11912988http://
HSL2496
Berkowitz BA, Sachs G.
Life Cycle of A Block Buster Drug: Discovery and Development of Omeprazole (PrilosecTM)
Mol Interv 2002 Feb; 2:(1):6-11
http://molinterv.aspetjournals.org/cgi/content/full/2/1/6, http://molinterv.aspetjournals.org/cgi/reprint/2/1/6,
HSL17982
Cooper R, Hoffman J.
Selling drugs to doctors--it's marketing, not education.
Br J Gen Pract 2002 Feb; 52:(475):168-9
http://www.ingentaconnect.com/content/rcgp/bjgp/2002/00000052/00000475;jsessionid=1csp69ve6uaku.alexandra?
HSL1662
This is your school on drugs
2002 Jan 31
HSL1663
Rovner J.
Generic Drugs Could Cut Cost of Medicare Benefit
2002 Jan 31
http://story.news.yahoo.com/news?tmpl=story&cid=594&u=/nm/20020131/hl_nm/drugs_2
HSL4525
Website targets DTC ads.
PMLive.com 2002 Jan 31
http://www.pmlive.com/archive.cfm?&ArticleID=4380&back=-1
HSL1661
Harris G.
Merck will be spinning off Merck-Medco.
Wall Street Journal 2002 Jan 29
http://online.wsj.com/article/SB1012254175800950080.html?mod=googlewsj
Page 134 of 144 pages ‹ First < 132 133 134 135 136 > Last ›
